The Cytodyn URL updates are definitely telegraphing a full

New Post Public Reply Private Reply Replies (2) Message Board
Plotinus Riztheinvestor #151883
800
The Cytodyn URL updates are definitely telegraphing a full court press on oncologic indications whilst not ignoring the sweep of indications under the pipeline page, which also leads with oncology. Dr Jay stated outright they see it is the shortest timeline to approval or partnership. More coming with the announcements at ESMO in Munich, but this from the last shareholders letter I think is already spelled out on your “our-science” sub-page. The oncology rationale and mechanism is not news to our group here but I expect they are going to bring it into focus at ESMO and with results that should startle, provide hope to anyone with TNBC (along with other high CCR5 expressing solid tumors), and likely a partnership which will put a floor under the company.

“we are excited to share more about the clarity forming around the putative mechanism of action of leronlimab in solid tumors…”

“The exciting survival outcomes announced in February 2025 provide early clinical evidence of leronlimab’s potential impact across the field of solid-tumor oncology. As previously announced, we’ve submitted our findings as an abstract to the European Society for Medical Oncology meeting in Munich, Germany in May 2025. We are eager to share additional insights into the apparent mechanism behind the survival outcomes and will do so once appropriate and in compliance with pre-conference publication and announcement allowances.”

Certainly not expecting this, however, per new FDA directors interview comments in some instances he can envision provisional approval based on sound mechanism of action, with the proviso of confirmatory data from patients that are treated. The FDA directors comments were related to rare diseases, TNBC is not rare but is in the spirit of devastating diagnosis with current regimens that are approved falling woefully short of anything tantamount to a “cure”. Strong case here for breakthrough therapy designation and some compelling action on the part of the agency.

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Foodsmart's Program Links Food Benefits to Health Gains

Updated Category News Views 3

Navigating the healthcare maze isn't for the faint of heart, especially when it comes to making sure that dollars spent on food benefits actually translate to improved health. Enter Foodsmart, the foodcare powerhouse that just rolled out its Food-is-Medicine Benefits Management (FBM) program. Turning Meals into Measurable Metrics Health plans are under mounting pressure...

Continue Reading
SureDone's Taska AI: Transforming Marketplace Listings

Updated Category News Views 5

Revolutionizing the E-Commerce Landscape Wake up and smell the innovation, folks! SureDone is rolling out Taska AI, a tool that's set to declutter the chaotic world of enterprise marketplace listings. It's no bed of roses for sellers out there, dealing with diverse channel demands and post-submission hiccups. Taska AI steps in as the seasoned handyman these sellers...

Continue Reading
Bay Crane's Bold Auction: A Strategic Fleet Update

Updated Category News Views 0

Bay Crane's Big Move: Strategic Fleet Update through Auction Well, here's a twist that gets the pulse racing for industry folk and machinery buffs. Bay Crane Companies, a powerhouse in the crane and hauling sector, has decided to go all in on a strategic fleet update. And what better way to move that iron than with a live, no-reserve auction? They've tapped Jeff Martin...

Continue Reading
Flux Expands AI Platform to Prove Engineering ROI

Updated Category News Views 7

Navigating the AI Maze: Flux's New Pathways Ever feel like these engineering platforms speak a language of their own? Flux's latest expansion finally offers a translator that matters. It's all about decoding whether your AI investment is delivering the goods. Engineering leaders now have more than just fluffy metrics; Flux breaks down real code-based evidence to show if...

Continue Reading
RunVermont Revamps City Marathon, Adds Half for 2027

Updated Category News Views 4

Straight outta Burlington, the M&T Bank Vermont City Marathon is giving its course a facelift and, get this, throwing a half marathon into the mix for 2027. It's about time they shook things up, considering how this race is supposed to be one of the most welcoming on the block. I mean, you're talking about a marathon that's practically been the crown jewel of Vermont's...

Continue Reading
Newmark's $482.5M Loan Fuels Steamboat Resort Expansion

Updated Category News Views 4

Newmark Banks on Steamboat's Future Diving headfirst into the deep end, Newmark (NASDAQ: NMRK) just roped in a colossal $482.5 million loan for a new gem in Steamboat Springs, Colorado. Inking a deal of this magnitude ain't your everyday rinse-and-repeat; it's a bold move that speaks volumes about where the big shots think value's heading. The Financial Fuel: GoldenTree...

Continue Reading
Class Action Lawsuit Targets Lincoln Educational Services

Updated Category News Views 4

Legal Maneuver Against Lincoln Educational Services Here we go again—another day, another lawsuit. The recent flap with Lincoln Educational Services Corporation (NASDAQ: LINC) is as classic as any market rug pull. Stepping into the spotlight, Wolf Haldenstein Adler Freeman & Herz LLP—a courtroom icon since 1888—has announced a class action lawsuit against Lincoln....

Continue Reading
BlueCollar Backs SuiteWorld 2026 with Platinum Sponsorship

Updated Category News Views 6

BlueCollar Cloud Aligns with SuiteWorld 2026 If you thought the construction ERP space was just a dusty office in a backlot, think again. BlueCollar Cloud is strapping on its boots and diving into the heart of SuiteWorld 2026 with a platinum sponsorship. This isn't just a walk in the park—it's a strategic power move, aligning themselves smack-dab in the middle of...

Continue Reading
IWP and SHARE Forge New Path for Filmmaker Funding

Updated Category News Views 4

Revolutionizing Film Financing The film industry has always been a tough nut to crack. Imagine trying to keep your creative baby yours without surrendering the crown jewels of intellectual property. Well, now, the cavalry with a fresh game plan has arrived, and both investors and filmmakers might be ready for another round. This isn't the typical PR fairytale; it's...

Continue Reading
Navigating Hit and Run Protocols in St. Tammany Parish

Updated Category News Views 2

When the Driver Disappears: Steps Forward Hit and run accidents can leave you feeling abandoned and unsure of what to do. In St. Tammany Parish, this scenario is all too familiar. Personal Injury Attorney Ross F. Lagarde cuts through the chaos, offering a clear path for those caught in this nightmare, explained in HelloNation's comprehensive guide. Prioritize Safety and...

Continue Reading

Top 5 Most Recently Viewed Articles

Revolutionizing Healthcare: Oracle and Partners' AI Innovation

Updated Category News Views 241

Transforming Healthcare Through AI Collaboration A partnership has emerged between Oracle Health, Cleveland Clinic, and G42 to establish an AI-powered global healthcare delivery platform. This initiative is set to enhance patient care and public health management through advanced AI technology, large-scale data analytics, and intelligent clinical applications. The goal is...

Continue Reading
Cepton, Inc. Investors Urged to Seek Legal Guidance on Lawsuit

Updated Category News Views 160

Cepton, Inc. Faces Class Action Lawsuit Cepton, Inc. (NASDAQ: CPTN) has recently become the focus of a class action lawsuit, which has sparked attention among shareholders. The allegations point to the potential misrepresentations by the company's leadership regarding significant developments in its business and operations. Shareholders who want to understand their rights...

Continue Reading
Kohl's Corp Faces Significant Decline in Stock Value

Updated Category News Views 193

Kohl's Corp Faces Significant Decline in Stock Value Kohl’s Corp (KSS) shares have experienced a staggering decline of over 33%, currently trading at $8.08. This downturn follows the company’s announcement of a significant 9.4% drop in fourth-quarter net sales, which has raised concerns about its overall performance in the retail sector. Understanding Kohl's Recent...

Continue Reading
Introducing New Fixed-Rate Bonds by Nykredit Realkredit A/S

Updated Category News Views 161

Nykredit Realkredit A/S Launches New Fixed-Rate Bonds Nykredit Realkredit A/S is excited to announce the introduction of new fixed-rate bonds designed to meet the needs of investors while contributing to financial stability. These bonds serve as a strategic response to recent changes in the interest rate landscape, ensuring that funding remains accessible and beneficial...

Continue Reading
La Rosa Holdings' Innovative Partnership with Lofty Enhances Growth

Updated Category News Views 189

Revolutionizing Agent Productivity with Lofty La Rosa Holdings Corp. (NASDAQ: LRHC), a notable player in the real estate and PropTech industry, is excited to unveil a strategic partnership with Lofty. This collaboration aims to revolutionize how agents within its extensive network operate and generate revenue. La Rosa is committed to empowering over 2,700 agents, ensuring...

Continue Reading